In a recent innovative approach, prolonged tumor retention could be achieved in mice models when using GRPR peptide radioligands, either agonists or antagonists, modified with cysteine cathepsin inhibitors, via an endolysosomal trapping mechanism [117]. Here, GRPR is linked to neoplasm.